Open access
2,038
Views
1
CrossRef citations to date
0
Altmetric
Report
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases
Maarten van der Lindena Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0000-0001-8597-4151View further author information
, Sangeeta Kumaria Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0000-0003-2131-102XView further author information
, Daphne Montizaana Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0000-0001-8514-0317View further author information
, Stephanie van Dalena Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0000-0003-2419-8544View further author information
, Annemarie Kipa Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0009-0003-1686-9755View further author information
, Martyn Fosterb Pathology, Experimental Pathology Consultancy, Benfleet, Essex, UKView further author information
, Inge Reinieren-Beerena Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Elsa Neubertc Department of Dermatology, Venereology and Allergology, University Medical Center, Göttingen University, Göttingen, Germany;d Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, NetherlandsView further author information
, Luise Erpenbeckc Department of Dermatology, Venereology and Allergology, University Medical Center, Göttingen University, Göttingen, Germany;e Department of General Dermatology and Venereology, Clinic of Skin Diseases, University Medical Center Münster, Münster, Germanyhttps://orcid.org/0000-0002-6561-472XView further author information
, Kelsy Waaijenberga Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0009-0005-8108-8781View further author information
, Tirza Bruurmijna Research and Development, Citryll B.V, Oss, The Netherlandshttps://orcid.org/0009-0007-1259-4570View further author information
, Rezie te Poelea Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Peter van Zandvoorta Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Paul Vinka Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Eric Meldruma Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
, Helmuth van Esa Research and Development, Citryll B.V, Oss, The NetherlandsView further author information
& Renato G.S. Chirivia Research and Development, Citryll B.V, Oss, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0003-4546-1559View further author information
show allhttps://orcid.org/0000-0003-4546-1559View further author information
Article: 2281763
|
Received 13 Jan 2023, Accepted 06 Nov 2023, Published online: 29 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.